{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:38:58Z","timestamp":1793392738772,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11910-019-0991-2","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T08:04:02Z","timestamp":1567152242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Assessment and Measurement of Spasticity in MS: State of the Evidence"],"prefix":"10.1007","volume":"19","author":[{"given":"Cinda L.","family":"Hugos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle H.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"issue":"10","key":"991_CR1","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029\u201340. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000007035\n\n.","journal-title":"Neurology"},{"issue":"5","key":"991_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","volume":"10","author":"MA Rizzo","year":"2004","unstructured":"Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10(5):589\u201395.","journal-title":"Mult Scler"},{"key":"991_CR3","unstructured":"Multiple Sclerosis Council for Clinical Practice Guidelines. Spasticity management and multiple sclerosis: evidence-based management strategies for spasticity in multiple sclerosis. 2003."},{"issue":"2","key":"991_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.pmr.2005.01.006","volume":"16","author":"J Haselkorn","year":"2005","unstructured":"Haselkorn J, Loomis S. Multiple sclerosis and spasticity. Phys Med Rehabil Clin N Am. 2005;16(2):467\u201381.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1","key":"991_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1352458514538884","volume":"21","author":"Y Nilsag\u00e5rd","year":"2015","unstructured":"Nilsag\u00e5rd Y, Gunn H, Freeman J, Hoang P, Lord S, Mazumder R, et al. Falls in people with MS--an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States. Mult Scler. 2015;21(1):92\u2013100. \nhttps:\/\/doi.org\/10.1177\/1352458514538884\n\n.","journal-title":"Mult Scler"},{"issue":"1","key":"991_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1682\/JRRD.2009.12.0192","volume":"48","author":"MH Cameron","year":"2011","unstructured":"Cameron MH, Poel AJ, Haselkorn JK, Linke A, Bourdette D. Falls requiring medical attention among veterans with multiple sclerosis: a cohort study. J Rehabil Res Dev. 2011;48(1):13\u201320.","journal-title":"J Rehabil Res Dev"},{"issue":"3","key":"991_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/NPT.0b013e31822a8c40","volume":"35","author":"JJ Sosnoff","year":"2011","unstructured":"Sosnoff JJ, Gappmaier E, Frame A, Motl RW. Influence of spasticity on mobility and balance in persons with multiple sclerosis. J Neurol Phys Ther. 2011;35(3):129\u201332. \nhttps:\/\/doi.org\/10.1097\/NPT.0b013e31822a8c40\n\n.","journal-title":"J Neurol Phys Ther"},{"issue":"1","key":"991_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/ane.12139","volume":"129","author":"J Svennson","year":"2014","unstructured":"Svennson J, Borg S, Nilsson P. Costs and quality of life in multiple sclerosis patients with spasticity. Acta Neurol Scand. 2014;129(1):13\u201320. \nhttps:\/\/doi.org\/10.1111\/ane.12139\n\n.","journal-title":"Acta Neurol Scand"},{"key":"991_CR9","doi-asserted-by":"publisher","first-page":"CD009974","DOI":"10.1002\/14651858.CD009974.pub2","volume":"2","author":"B Amatya","year":"2013","unstructured":"Amatya B, Khan F, La Mantia L, Demetrios M, Wade DT. Non pharmacological interventions for spasticity in multiple sclerosis. Cochrane Database Syst Rev. 2013;2:CD009974. \nhttps:\/\/doi.org\/10.1002\/14651858.CD009974.pub2\n\n.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"991_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.pmr.2013.07.003","volume":"24","author":"C Hughes","year":"2013","unstructured":"Hughes C, Howard IM. Spasticity management in multiple sclerosis. Phys Med Rehabil Clin N Am. 2013;24(4):593\u2013604. \nhttps:\/\/doi.org\/10.1016\/j.pmr.2013.07.003\n\n.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"991_CR11","first-page":"485","volume-title":"Spasticity: disorder of motor control","author":"JW Lance","year":"1980","unstructured":"Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disorder of motor control. Chicago: Year Book Medical Publishers; 1980. p. 485\u201394."},{"issue":"6","key":"991_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/archneur.1997.00550180049011","volume":"54","author":"PW Nance","year":"1997","unstructured":"Nance PW, Sheremata WA, Lynch SG, Vollmer T, Hudson S, Francis GS, et al. Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis. Arch Neurol. 1997;54(6):731\u20136.","journal-title":"Arch Neurol"},{"key":"991_CR13","first-page":"540","volume":"192","author":"B Ashworth","year":"1964","unstructured":"Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540\u20132.","journal-title":"Practitioner"},{"key":"991_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"RW Bohannon","year":"1987","unstructured":"Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther. 1987;67:206\u20137.","journal-title":"Phys Ther"},{"key":"991_CR15","unstructured":"Shirley Ryan Ability Lab website \nhttps:\/\/www.sralab.org\/rehabilitation-measures\n\n. Accessed June 2019."},{"key":"991_CR16","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1111\/j.1468-1331.1999.tb0031.x","volume":"6","author":"RN Boyd","year":"1999","unstructured":"Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. 1999;6:S4. \nhttps:\/\/doi.org\/10.1111\/j.1468-1331.1999.tb0031.x\n\n.","journal-title":"Eur J Neurol"},{"issue":"1","key":"991_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10072-016-2714-7","volume":"38","author":"S Naghdi","year":"2017","unstructured":"\u2022 Naghdi S, Ansari NN, Ghorbani-Rad S, Senobari M, Sahraian MA. Intra-rater reliability of the Modified Tardieu Scale in patients with multiple sclerosis. Neurol Sci. 2017;38(1):93\u20139. \nhttps:\/\/doi.org\/10.1007\/s10072-016-2714-7\n\n These authors concluded that intra-rater reliability for the MTS when assessing lower limb muscle spasticity in PwMS by a physical therapist with no previous experience in the scale, and with limited training, is not good.","journal-title":"Neurol Sci"},{"key":"991_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.1.1.18","volume":"1","author":"R Wartenberg","year":"1951","unstructured":"Wartenberg R. Pendulousness of the legs as a diagnostic test. Neurology. 1951;1:18\u201324 From 4th International Neurological Congress, 1949.","journal-title":"Neurology"},{"issue":"1","key":"991_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.gaitpost.2012.11.003","volume":"38","author":"L Bar-On","year":"2013","unstructured":"Bar-On L, Aertbeli\u00ebn E, Wambacq H, Severijns D, Lambrecht K, Dan C, et al. A clinical measurement to quantify spasticity in children with cerebral palsy by integration of multidimensional signals. Gait Posture. 2013;38(1):141\u20137.","journal-title":"Gait Posture"},{"issue":"3","key":"991_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.apmr.2013.08.010","volume":"95","author":"L Bar-On","year":"2014","unstructured":"Bar-On L, Van Campenhout A, Desloovere K, Aertbeli\u00ebn E, Huenaerts C, Vandendoorent B, et al. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy? Arch Phys Med Rehabil. 2014;95(3):515\u201323. \nhttps:\/\/doi.org\/10.1016\/j.apmr.2013.08.010\n\n.","journal-title":"Arch Phys Med Rehabil"},{"key":"991_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0003-9993(95)80026-3","volume":"76","author":"B Stillman","year":"1995","unstructured":"Stillman B, Phty D, McMeeken J. A video-based version of the pendulum test: technique and normal response. Arch Phys Med Rehabil. 1995;76:166\u201376.","journal-title":"Arch Phys Med Rehabil"},{"issue":"suppl 9","key":"991_CR22","first-page":"S44","volume":"44","author":"PW Nance","year":"1994","unstructured":"Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Azizala A. the North American Tizanidine Study GroupEfficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. Neurol. 1994;44(suppl 9):S44\u201352.","journal-title":"Neurol"},{"key":"991_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/09638280400014600","volume":"27","author":"GE Voerman","year":"2005","unstructured":"Voerman GE, Gregoric M, Hermens HJ. Neurophysiological methods for the assessment of spasticity: the Hoffmann reflex, the tendon reflex, and the stretch reflex. Disabil Rehabil. 2005;27:33\u201368.","journal-title":"Disabil Rehabil"},{"issue":"1","key":"991_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.apmr.2009.09.013","volume":"91","author":"JJ Sosnoff","year":"2010","unstructured":"Sosnoff JJ, Shin S, Motl RW. Multiple sclerosis and postural control: the role of spasticity. Arch Phys Med Rehabil. 2010;91(1):93\u20139. \nhttps:\/\/doi.org\/10.1016\/j.apmr.2009.09.013\n\n.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"991_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10072-016-2780-x","volume":"38","author":"G Illomei","year":"2017","unstructured":"\u2022 Illomei G, Spinicci G, Locci E, Marrosu MG. Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement. Neurol Sci. 2017;38(3):433\u20139. \nhttps:\/\/doi.org\/10.1007\/s10072-016-2780-x\n\n These authors describe muscle elastography, a new approach to quantifying spasticity using ultrasound, and report strong correlation with the Ashworth Scale and similar responsiveness to the Numeric Rating Scale for Spasticity.","journal-title":"Neurol Sci"},{"issue":"10","key":"991_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/dmcn.12419","volume":"56","author":"L Bar-On","year":"2014","unstructured":"Bar-On L, Aertbeli\u00ebn E, Molenaers G, Dan B, Desloovere K. Manually controlled instrumented spasticity assessments: a systematic review of psychometric properties. Dev Med Child Neurol. 2014;56(10):932\u201350. \nhttps:\/\/doi.org\/10.1111\/dmcn.12419\n\n.","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"991_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1682\/JRRD.2013.08.0186","volume":"51","author":"TR Kremer","year":"2014","unstructured":"Kremer TR, Van Dillen LR, Wagner JM. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis. J Rehabil Res Dev. 2014;51(6):975\u201384.","journal-title":"J Rehabil Res Dev"},{"key":"991_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clinbiomech.2016.05.013","volume":"37","author":"J Ofori","year":"2016","unstructured":"Ofori J, Freeman J, Logan A, Rapson R, Zajieck J, Hobart J, et al. An investigation of commonly prescribed stretches of the ankle plantarflexors in people with multiple sclerosis. Clin Biomech. 2016;37:22\u20136. \nhttps:\/\/doi.org\/10.1016\/j.clinbiomech.2016.05.013\n\n.","journal-title":"Clin Biomech"},{"issue":"4","key":"991_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/MLR.0b013e3182064aa2","volume":"49","author":"MA Dinan","year":"2011","unstructured":"Dinan MA, Compton KL, Dhillon JK, Hammill BG, DeWitt EM, Weinfurt KP, et al. Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. Med Care. 2011;49(4):415\u20139.","journal-title":"Med Care"},{"issue":"23","key":"991_CR30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","volume":"320","author":"RD Penn","year":"1989","unstructured":"Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320(23):1517\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"991_CR31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jnnp.73.6.705","volume":"73","author":"L Jarrett","year":"2002","unstructured":"Jarrett L, Nandi P, Thompson AJ. Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? J Neurol Neurosurg Psychiatry. 2002;73(6):705\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"991_CR32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.clinthera.2008.05.011","volume":"30","author":"JT Farrar","year":"2008","unstructured":"Farrar JT, Troxel AB, Stott C, Duncombe P, Jensen MP. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther. 2008;30(5):974\u201385. \nhttps:\/\/doi.org\/10.1016\/j.clinthera.2008.05.011\n\n.","journal-title":"Clin Ther"},{"key":"991_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/brain\/awh675","volume":"129","author":"JC Hobart","year":"2006","unstructured":"Hobart JC, Riazi A, Thompson AJ, Stiles IM, Ingram W, Vickery PJ, et al. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Brain. 2006;129:224\u201334.","journal-title":"Brain"},{"key":"991_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12955-014-0119-y","volume":"12","author":"T Henze","year":"2014","unstructured":"Henze T, von Mackensen S, Lehrieder G, Zettl UK, Pfiffner C, Flachenecker P. Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany. Health Qual Life Outcomes. 2014;12:119.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"991_CR35","doi-asserted-by":"publisher","first-page":"e0147042","DOI":"10.1371\/journal.pone.0147042","volume":"11","author":"SZ Rodic","year":"2016","unstructured":"Rodic SZ, Knezevic TI, Kisic-Tepavcevic DB, Dackovic JR, Dujmovic I, Pekmeovic TD, et al. Validation of the Serbian version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88). PLoS One. 2016;11(1):e0147042. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0147042\n\n.","journal-title":"PLoS One"},{"issue":"5","key":"991_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1191\/026921599677595404","volume":"13","author":"AD Pandyan","year":"1999","unstructured":"Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitations of the Ashworth and Modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999;13(5):373\u201383. \nhttps:\/\/doi.org\/10.1191\/026921599677595404\n\n.","journal-title":"Clin Rehabil"},{"key":"991_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/0269215508101747","volume":"23","author":"S Malhotra","year":"2009","unstructured":"Malhotra S, Pandyan AD. Spasticity, an impairment that is poorly defined and poorly measured. Clin Rehabil. 2009;23:651\u20138.","journal-title":"Clin Rehabil"},{"issue":"1","key":"991_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/jnnp.2009.177071","volume":"81","author":"JFM Fleuren","year":"2010","unstructured":"Fleuren JFM, Voerman GE, Erren-Wolters CV, Snoek GJ, Rietman JS, Hermens HJ, et al. Stop using the Ashworth Scale for the assessment of spasticity. J Neurol Neurosurg Psychiatry. 2010;81(1):46\u201353. \nhttps:\/\/doi.org\/10.1136\/jnnp.2009.177071\n\n.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-019-0991-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:48:26Z","timestamp":1598658506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-019-0991-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1007\/s11910-019-0991-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"30 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Cinda L. Hugos declares no potential conflicts of interest. Michelle H. Cameron reports consulting fees from Adamas Pharmaceuticals and Greenwich Bioscience\/GW Pharmaceuticals, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"79"}}